Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Clin Immunol. 2010 May 15;136(3):400–408. doi: 10.1016/j.clim.2010.04.016

Figure 2. In vitro naïve T cell proliferation is greater in HIV-infected patients who respond to immunization with neoantigen, but not recall antigen.

Figure 2

Boxes represent the median, and error bars represent the interquartile range, of percent Vβ3+ or Vβ5+ T cells that proliferate after TCR stimulation in responders (light boxes) or non-responders (dark boxes) to the neoantigen KLH (top row) or the recall antigen tetanus toxoid (bottom row). Responses are consistently greater in all assays among responders to KLH, but not tetanus toxoid.